Development and characterization of polymeric nanoparticles containing ondansetron hydrochloride as a hydrophilic drug

被引:7
|
作者
Ozdal, Zeliha Duygu [1 ]
Gultekin, Yakup [2 ]
Vural, Imran [2 ]
Takka, Sevgi [1 ]
机构
[1] Gazi Univ, Dept Pharmaceut Technol, Fac Pharm, Ankara, Turkey
[2] Hacettepe Univ, Dept Pharmaceut Technol, Fac Pharm, Ankara, Turkey
关键词
Ondansetron HCl; Polymeric nanoparticles; PLGA; Controlled release; Double emulsion solvent evaporation method; Cell viability study; LOADED PLGA NANOPARTICLES; IN-VITRO EVALUATION; TRANSDERMAL DELIVERY; HYBRID NANOPARTICLES; BRAIN DELIVERY; FORMULATION; OPTIMIZATION; RELEASE; MICROSPHERES; DESIGN;
D O I
10.1016/j.jddst.2022.103599
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The encapsulation of hydrophilic drugs is still a challenge due to their tendency to leak into the outer aqueous phase. The aim of the study is to develop and evaluate Ondansetron HCl (OND) loaded controlled release polymeric nanoparticles with high encapsulation efficiency (EE). Polymeric nanoparticles (PNPs) were prepared with two different types of polycaprolactone and five different types of poly (d, l-lactide-co-glycolide) (PLGA) by the double emulsion solvent evaporation method. The effects of formulation variables on the particle size, zeta potential, encapsulation efficiency, and drug release of OND loaded PNPs were investigated. The particle size, PDI, and zeta potential of the optimum formulation were 342.5 +/- 6.7 nm, 0.240 +/- 0.020, and 20.1 +/- 0.51 mV, respectively, whereas the encapsulation efficiency was 46.8 +/- 2.78%. The optimum formulation was pegylated to prolong the residence time in circulation. Transmission electron microscopy (TEM) images confirmed the spherical shape of nanoparticles. Pegylated formulation had 47.76 +/- 1.69% encapsulation efficiency and sustained release profile (92.7 +/- 5.7% in 72 h). Differential Calorimetry and Fourier Transform Infrared Spectroscopy indicated that the drug and excipients were compatible and the drug was encapsulated into nanoparticles. The comparison of drug release profiles demonstrated that drug release from nanoparticles prepared with both higher molecular weight and higher concentration polymers decelerated but the drug release accelerated as the amount of glycolide in the copolymer composition increased. Weibull kinetic model was found to fit best for OND release from PLGA-PNPs. The cytotoxicity effect of the pure drug, marketed drug (Zofer (R)), and optimized formulations were tested in the L929 cell line, and the results exhibited that the cell viability of optimized pegylated formulation was higher than 90% after 48 h of incubation.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Hydrophilic polymeric nanoparticles as drug carriers
    Ghosh, PK
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2000, 37 (05): : 273 - 282
  • [2] Development of sublingual spray formulation containing ondansetron hydrochloride dihydrate
    Chokshi, Ashish
    Vangara, Kiran
    Chilampalli, Shivani
    Narayanan, Eshwaran
    Potta, Thrimoorthy
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2019, 53
  • [3] Formulation development and characterization of polymeric nanoparticles of antituberculosis drug Isoniazid
    Saurabh, Srivastava
    Irfan, Ahmad
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2018, 13 (08): : 22 - 26
  • [4] Development and characterization of an orodispersible film containing drug nanoparticles
    Shen, Bao-de
    Shen, Cheng-ying
    Yuan, Xu-dong
    Bai, Jin-xia
    Lv, Qing-yuan
    Xu, He
    Dai, Ling
    Yu, Chao
    Han, Jin
    Yuan, Hai-long
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (03) : 1348 - 1356
  • [5] Polymeric nanoparticles containing babassu oil: A proposed drug delivery system for controlled release of hydrophilic compounds
    de Oliveira, Joao Vitor Raupp
    Silveira, Pedro Leardin
    Spingolon, Gabriela
    Alves, Gabriel Antonio Lopes
    Pena, Flavia Pires
    Aguirre, Tanira Alessandra Silveira
    CHEMISTRY AND PHYSICS OF LIPIDS, 2023, 253
  • [6] Development of a polymeric nanoparticulate drug delivery system - In vitro characterization of nanoparticles based on sugar-containing conjugates
    Kim, IS
    Kim, SH
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 245 (1-2) : 67 - 73
  • [7] Development of HPTLC method for the estimation of ondansetron hydrochloride in bulk drug and sublingual tablets
    Mujtaba, Ali
    Kohli, Kanchan
    Ali, J.
    Baboota, Sanjula
    DRUG TESTING AND ANALYSIS, 2013, 5 (02) : 122 - 125
  • [8] Selecting Counterions to Improve Ionized Hydrophilic Drug Encapsulation in Polymeric Nanoparticles
    Dimiou, Savvas
    McCabe, James
    Booth, Rebecca
    Booth, Jonathan
    Nidadavole, Kalyan
    Svensson, Olof
    Sparen, Anders
    Lindfors, Lennart
    Paraskevopoulou, Vasiliki
    Mead, Heather
    Coates, Lydia
    Workman, David
    Martin, Dave
    Treacher, Kevin
    Puri, Sanyogitta
    Taylor, Lynne S.
    Yang, Bin
    MOLECULAR PHARMACEUTICS, 2023, 20 (02) : 1138 - 1155
  • [9] Gliadin Nanoparticles Containing Doxorubicin Hydrochloride: Characterization and Cytotoxicity
    Voci, Silvia
    Gagliardi, Agnese
    Ambrosio, Nicola
    Salvatici, Maria Cristina
    Fresta, Massimo
    Cosco, Donato
    PHARMACEUTICS, 2023, 15 (01)
  • [10] Development and Characterization of Nanoparticles for the Delivery of Gemcitabine Hydrochloride
    Khaira, Rekha
    Sharma, Jyoti
    Saini, Vinay
    SCIENTIFIC WORLD JOURNAL, 2014,